Med-e-Tel 2010 - Annual, International Telemedicine and eHealth Forum

The 8th edition of Med-e-Tel, the International eHealth, Telemedicine and Health ICT Forum, will take place on 14-16 April 2010 at Luxexpo, the Luxembourg Exhibition and Congress Center. Med-e-Tel, organized by the International Society for Telemedicine & eHealth (ISfTeH), is one of the premier events worldwide in the field of Telemedicine and eHealth and brings together every year participants from 50 countries around the world. The ISfTeH is the international federation of national Telemedicine/eHealth associations and is recognized as an NGO in Official Relations with the World Health Organization (WHO).

Med-e-Tel is endorsed by the Luxembourg Ministry of Health, the European Commission, the International Council of Nurses (ICN), the International Association for CyberPsychology, Training and Rehabilitation (iACToR), European Health Telematics Association (EHTEL) and works together with a wide range of local and international partners who are all involved in Telemedicine and eHealth research, development, funding or implementation.

Through its extensive conference program with over 200 presentations and through an industrial exhibition and networking area, Med-e-Tel presents and showcases practical experiences, ongoing projects and recent research results with a high added value for its international audience of healthcare providers, industry representatives, consultants, researchers and policy makers.

Next to the international focus and participation of several high level (Ministry of Health) delegations from countries in Africa, Asia and South America, Med-e-Tel also features a regional seminar aimed primarily at the Luxembourg and Belgian marketplace. The 2010 edition of this seminar focuses on "New Models of Care and New ICT Solutions" and is supported by global management consulting company Accenture and leading healthcare publication Healthcare Executive. The seminar presents actual cases and recognized experts from Luxembourg, Belgium, France and Switzerland. It is targeted at hospitals, homecare service providers, mutualities, government representatives and industry leaders from Luxembourg and Belgium.

The inaugural ceremony of Med-e-Tel 2010 on April 14th will be held in the presence of Mars Di Bartolomeo, Luxembourg Minister of Health, Prof. Yunkap Kwankam, Executive Director of the ISfTeH and Karl Brown, Associate Director of The Rockefeller Foundation. The ceremony will be followed by a tour of the exhibition and an opening session in which experts and thought leaders from the European Commission, International Council of Nurses, mHealth (Mobile Health) Initiative, Austrian Insitute of Technology, WorldVistA and Virtual Reality Medical Institute will provide a global update on Telemedicine and eHealth.

"The International Society for Telemedicine & eHealth is all about facilitating the dissemination of knowledge and experience in Telemedicine and eHealth. Med-e-Tel is one of the instruments that help us to realize this mission," says Yunkap Kwankam, Executive Director of the ISfTeH. "The Med-e-Tel credo of providing information and education, enhancing networking opportunities and facilitating business relationships, is fully in line with the ISfTeH strategy of establishing and fostering relationships on a global scale between all actors and organizations involved in Telemedicine and eHealth and advancing the knowledge and use of ICT tools in the delivery of health and social care. We are very pleased to hold this event every year in Luxembourg and to successfully attract an international audience," concludes Kwankam.

The three day Med-e-Tel conference program will include additional sessions and workshops on the topics of home care and assisted living, open source software in health care, elearning, mobile health, telecardiology, closing the health care gap in developing countries, and more.

The event also includes an expo and networking area which will feature companies and organizations such as A&D Medical, Accenture, Aerotel Medical Systems, Aipermon, Anoto, Austrian Institute of Technology, BioRICS, Card Guard, Diatelic, DICSIT Informatique, DSM TCG, eHealth Business Services, Ericsson, European Commission, International Society for Telemedicine & eHealth and several of its national member organizations, Leuven Medical Technology Centre, Link Care Services, MEDGATE, medXchange, MIR Medical International Research, RS TechMedic, Sensatys, THOR Medical Systems, Tiani Spirit, Transinsight as well as various publications and online information services that will be featured in the event's media corner.

Overall, Med-e-Tel promotes and enhances cooperation opportunities and is the place to meet and network with healthcare and industry stakeholders from some 50 countries in Europe and beyond.

For further information and registration, please visit:
http://www.medetel.eu

About Med-e-Tel
Med-e-Tel focuses on ehealth and telemedicine applications and a wide range of other medical ICT applications and on the convergence of information and communication technology with medical applications, which lead to higher quality of care, cost reductions, workflow efficiency, and widespread availability of healthcare services.

The "Med" in Med-e-Tel stands for healthcare services (institutional and home based care, prevention and education) and for medical products and equipment (medical imaging equipment, monitoring devices, electronic health records, etc.).
The "e" stands for the electronic and IT industry and services (hard- & software, internet, e-mail, etc.).
The "Tel" stands for telecommunications (whether it is POTS, ISDN, wireless, satellite, videoconferencing, VoIP, or other).

For further information, please visit www.medetel.eu.

Most Popular Now

Cannabis extract helps reset brain function in psy…

Research from King's College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psyc...

New cancer treatment uses enzymes to boost immune …

Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy. The enzyme, PEG-KYNase, does not directly kill can...

Bayer accelerates six new startups

Changing the experience of health: that's the focus of the six startups which the Bayer G4A team has included in the Accelerator program this year. The young companies fr...

Novartis receives European Commission approval of …

Novartis today announced that the European Commission (EC) has approved Kymriah® (tisagenlecleucel, formerly CTL019). The approved indications are for the treatment of pe...

Antioxidant reduces risk for second heart attack, …

Doctors have long known that in the months after a heart attack or stroke, patients are more likely to have another attack or stroke. Now, a paper in the Journal of the A...

Shire completes sale of oncology franchise

Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it has completed the sale of its Oncology franchise to Servier S.A.S. for $2.4 billion. The franchise includes the...

Novartis to divest the Sandoz US dermatology busin…

Novartis today announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids po...

Tezepelumab granted Breakthrough Therapy Designati…

AstraZeneca and its partner Amgen Inc. (Amgen) today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab...

Pfizer terminates domagrozumab (PF-06252616) clini…

Pfizer Inc. (NYSE: PFE) announced that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrop...

New tablet production facility in Ingelheim: Cente…

Boehringer Ingelheim held a groundbreaking ceremony for the construction of a new production facility for innovative drugs. This new Solids Launch facility will focus on ...

Study links widely-used drug azathioprine to skin …

A drug used to treat inflammatory bowel disease, arthritis and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an important...

Pfizer and Astellas amend clinical research protoc…

Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced amendments to the protocols for two registratio...